Biophytis S.A. Cash Flow Conversion Efficiency

Latest as of June 2025: 0.472x

Biophytis S.A. cash flow conversion efficiency. Based on the latest financial reports, Biophytis S.A. (ALBPS) has a cash flow conversion efficiency ratio of 0.472x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.69 Million ≈ $-4.32 Million USD) by net assets (€-7.82 Million ≈ $-9.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Biophytis S.A. (2013–2024)

Cash flow conversion efficiency of Biophytis S.A. from 2013 to 2024. This chart illustrates how Biophytis S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View ALBPS live share price for real-time trading data and today's change.

Biophytis S.A. Cash Flow Conversion Ratio Explained

Biophytis S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Biophytis S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biophytis S.A. ranked by their cash flow conversion efficiency. Also see ALBPS stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Im Cannabis Corp NASDAQ:IMCC	-1.169x
Central China Real Estate Limited F:AJ5	-0.088x
CBEYOND F:C5B	0.724x
Baker Steel Resources Trust LSE:BSRT	-0.006x
Avinger Inc NASDAQ:AVGR	-0.738x
BELGRAVIA HARTFORD CAP. F:ECA	1.398x
Next Biometrics Group ASA OL:NEXT	-1.469x
Pharos Energy plc LSE:PHAR	0.058x

Annual Cash Flow Conversion Efficiency for Biophytis S.A. (2013–2024)

The table below shows the annual cash flow conversion efficiency of Biophytis S.A. from 2013 to 2024. Review Biophytis S.A. free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-9.70 Million ≈ $-11.34 Million	€-8.64 Million ≈ $-10.10 Million	0.891x	-73.09%
2023-12-31	€-3.89 Million ≈ $-4.55 Million	€-12.87 Million ≈ $-15.05 Million	3.310x	-66.69%
2022-12-31	€-1.91 Million ≈ $-2.23 Million	€-18.99 Million ≈ $-22.20 Million	9.936x	+338.23%
2021-12-31	€5.71 Million ≈ $6.67 Million	€-23.80 Million ≈ $-27.82 Million	-4.171x	-188.88%
2020-12-31	€6.83 Million ≈ $7.99 Million	€-9.86 Million ≈ $-11.53 Million	-1.444x	-171.15%
2019-12-31	€-7.53 Million ≈ $-8.80 Million	€-15.27 Million ≈ $-17.86 Million	2.029x	+217.92%
2018-12-31	€7.01 Million ≈ $8.19 Million	€-12.06 Million ≈ $-14.10 Million	-1.721x	-317.79%
2017-12-31	€21.19 Million ≈ $24.77 Million	€-8.73 Million ≈ $-10.20 Million	-0.412x	+71.94%
2016-12-31	€4.52 Million ≈ $5.28 Million	€-6.63 Million ≈ $-7.75 Million	-1.468x	-433.55%
2015-12-31	€11.67 Million ≈ $13.64 Million	€-3.21 Million ≈ $-3.75 Million	-0.275x	-147.13%
2014-12-31	€-1.13 Million ≈ $-1.32 Million	€-658.89K ≈ $-770.31K	0.584x	-70.26%
2013-12-31	€-409.32K ≈ $-478.54K	€-803.29K ≈ $-939.14K	1.962x	--

About Biophytis S.A.

PA:ALBPS France Biotechnology

Market Cap

$1.52 Million

€1.30 Million EUR

Market Cap Rank

#30328 Global

#559 in France

Share Price

€0.03

Change (1 day)

-7.78%

52-Week Range

€0.01 - €0.13

All Time High

€4896.00